Semaglutide and heart failure: Updated meta-analysis

• Published in: Current problems in cardiology Vol. 49; no. 9; p. 102721
• Main Authors: Barbagelata, Leandro, Masson, Walter, Lobo, Martín, Bluro, Ignacio
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01.09.2024
• Subjects: Diabetes mellitus; Glucagon-Like Peptide-1 Receptor Agonists; Glucagon-Like Peptides - adverse effects; Glucagon-Like Peptides - therapeutic use; Heart failure; Heart Failure - drug therapy; Humans; Hypoglycemic Agents - adverse effects; Hypoglycemic Agents - therapeutic use; Randomized Controlled Trials as Topic; Semaglutide; Treatment Outcome; Heart failure; Semaglutide; Glucagon-like peptide-1 receptor agonists; Diabetes mellitus

Heart failure (HF) is a major contributor to global health challenges, affecting mortality rates and healthcare expenditure. Glucagon-like peptide-1 receptor agonists (GLP-1RA) offer promise in HF management, though their precise impact is unclear. The main objective of this study was to evaluate th...